
Sign up to save your podcasts
Or


Dr Ellie Cannon is joined by Dr Jacqueline Barry, Chief Clinical Officer at the Cell and Gene Therapy Catapult and Owen Marks, Rare Disease Lead at Pfizer UK (at time of recording), to discuss the urgent need to evolve the way rare disease medicines are brought to patients, and why healthcare systems need to keep pace with scientific advancements.
PP-UNP-GBR-12704 / July 2025
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
By Pfizer3
11 ratings
Dr Ellie Cannon is joined by Dr Jacqueline Barry, Chief Clinical Officer at the Cell and Gene Therapy Catapult and Owen Marks, Rare Disease Lead at Pfizer UK (at time of recording), to discuss the urgent need to evolve the way rare disease medicines are brought to patients, and why healthcare systems need to keep pace with scientific advancements.
PP-UNP-GBR-12704 / July 2025
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

2,109 Listeners

610 Listeners

78 Listeners

418 Listeners

826 Listeners

247 Listeners

372 Listeners

989 Listeners

140 Listeners

765 Listeners

27 Listeners

32 Listeners

94 Listeners

3,141 Listeners

1,049 Listeners

965 Listeners

0 Listeners

0 Listeners

118 Listeners

346 Listeners

0 Listeners

0 Listeners